Intrahepatic bile duct adenoma in a patient with gastric cancer.
Benign tumor
Bile duct adenoma
Gastric cancer
Intrahepatic bile duct
Journal
International cancer conference journal
ISSN: 2192-3183
Titre abrégé: Int Cancer Conf J
Pays: Singapore
ID NLM: 101734231
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
07
08
2018
accepted:
10
09
2018
entrez:
1
6
2019
pubmed:
1
6
2019
medline:
1
6
2019
Statut:
epublish
Résumé
We report a case of intrahepatic bile duct adenoma (BDA) detected during laparoscopic distal gastrectomy for gastric cancer. A 70-year-old man was referred to our hospital for the treatment of gastric cancer. Esophagogastroduodenoscopy revealed an irregular, nodular, and elevated lesion on the greater curvature side of the middle third of the stomach. Abdominal contrast-enhanced computed tomography showed wall thickening with homogeneous enhancement in the middle part of the stomach, and no lesions in the liver. The patient underwent laparoscopic distal gastrectomy with regional lymphadenectomy, and during the operation a small whitish nodule was observed on the lateral segment of the liver surface. The lesion was excised by partial resection of the liver for the purpose of both histological diagnosis and treatment. Pathological examination of the liver lesion revealed no structural or cellular atypia, no stromal invasion, and immunohistochemical positivity for CK7 and CK19, but negativity for p53. The final diagnosis was well-differentiated adenocarcinoma invading the gastric serosal layer without lymph node metastasis, and intrahepatic BDA measuring 0.4 × 0.3 cm. Following surgery, the patient remained symptom-free without evidence of recurrence for 5 months. To the best of our knowledge, this is the first case of BDA with gastric cancer. Because it is difficult to distinguish BDA from other liver tumors including metastatic cancer due to its characteristically small size and lack of specific morphological features on standard imaging, surgical resection should be considered as the most suitable approach for both accurate diagnosis and treatment.
Identifiants
pubmed: 31149539
doi: 10.1007/s13691-018-0345-y
pii: 345
pmc: PMC6498292
doi:
Types de publication
Case Reports
Langues
eng
Pagination
7-11Déclaration de conflit d'intérêts
All authors declare that they have no conflict of interest.All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.Informed consent was obtained from all patients for being included in the study.
Références
Gastric Cancer. 2013 Jan;16(1):1-27
pubmed: 22729699
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Lancet Oncol. 2017 Dec;18(12):1579-1589
pubmed: 29111259
AJR Am J Roentgenol. 2015 Jul;205(1):W56-66
pubmed: 26102419
Pathol Int. 2016 Nov;66(11):640-642
pubmed: 27663997
Am J Surg Pathol. 2001 Jul;25(7):956-60
pubmed: 11420469
Lancet Oncol. 2017 Jul;18(7):849-851
pubmed: 28677562
World J Surg Oncol. 2014 Apr 26;12:125
pubmed: 24767257
Am J Surg Pathol. 1988 Sep;12(9):708-15
pubmed: 3046396
Med Mol Morphol. 2018 Dec;51(4):187-193
pubmed: 29619546
Surg Today. 2015 Dec;45(12):1467-74
pubmed: 25820596
Ultrasonography. 2018 Jan;37(1):25-35
pubmed: 28830058